Literature DB >> 28872123

Ileectomy-induced Bile Overaccumulation in Mouse Intestine.

Rongli Zhang1, Jonathan W Ray2, Mukesh K Jain3, Shuxin Han4.   

Abstract

Intestinal resection is a common therapeutic approach for human diseases such as obesity, inflammatory bowel disease, Crohn's disease, and colon cancer that often results in severe short bowel syndrome-like adverse effects including bile acid diarrhea, dehydration, electrolyte disturbances, and nutrient malabsorption. Here we introduce a murine ileal resection model, termed ileectomy, to evaluate tissue communication and the maintenance of systemic homeostasis. After ileal resection, circulating blood is permanently devoid of the ileum-specific endocrine hormone fibroblast growth factor 15 (FGF15), which releases its endocrinal inhibition of bile acid synthesis in the liver. In combination with the increased production and abolished reabsorption of bile acids after removing the ileum, mice that underwent surgery suffer from bile salt overaccumulation in the intestine and associated diarrhea, morbidity, and mortality. Novel usage of the surgery model introduced in this study may provide mechanistic and functional insights into ileal control of systemic metabolic regulation in physiology and disease.

Entities:  

Mesh:

Year:  2017        PMID: 28872123      PMCID: PMC5614358          DOI: 10.3791/55728

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  19 in total

Review 1.  AGA technical review on short bowel syndrome and intestinal transplantation.

Authors:  Alan L Buchman; James Scolapio; Jon Fryer
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

Review 2.  Review article: bile acid diarrhoea - pathogenesis, diagnosis and management.

Authors:  N Mottacki; M Simrén; A Bajor
Journal:  Aliment Pharmacol Ther       Date:  2016-02-24       Impact factor: 8.171

Review 3.  Advances in understanding of bile acid diarrhea.

Authors:  Michael Camilleri
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11-25       Impact factor: 3.869

4.  Cholestyramine treatment of diarrhea associated with ileal resection.

Authors:  A F Hofmann; J R Poley
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

5.  Intestinal adaptation following massive small bowel resection in the mouse.

Authors:  M A Helmrath; W E VanderKolk; G Can; C R Erwin; B W Warner
Journal:  J Am Coll Surg       Date:  1996-11       Impact factor: 6.113

6.  Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Authors:  Klementina Fon Tacer; Angie L Bookout; Xunshan Ding; Hiroshi Kurosu; George B John; Lei Wang; Regina Goetz; Moosa Mohammadi; Makoto Kuro-o; David J Mangelsdorf; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2010-07-28

7.  The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.

Authors:  Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

Review 8.  Beyond intestinal soap--bile acids in metabolic control.

Authors:  Folkert Kuipers; Vincent W Bloks; Albert K Groen
Journal:  Nat Rev Endocrinol       Date:  2014-05-13       Impact factor: 43.330

9.  FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.

Authors:  Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 10.  Bile Acid diarrhea: prevalence, pathogenesis, and therapy.

Authors:  Michael Camilleri
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more
  2 in total

1.  Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.

Authors:  Tianying Duan; Onur Cil; C Ming Tse; Rafiquel Sarker; Ruxian Lin; Mark Donowitz; Alan S Verkman
Journal:  FASEB J       Date:  2019-07-03       Impact factor: 5.834

Review 2.  Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention.

Authors:  Danny Orabi; Nathan A Berger; J Mark Brown
Journal:  Cancers (Basel)       Date:  2021-07-11       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.